Kaempferol ameliorates symptoms of metabolic syndrome by regulating activities of liver X receptor-β

Minh Hien Hoang, Yaoyao Jia, Boram Mok, Hee jin Jun, Kwang Yeon Hwang, Sung-Joon Lee

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Kaempferol is a dietary flavonol previously shown to regulate cellular lipid and glucose metabolism. However, its molecular mechanisms of action and target proteins have remained elusive, probably due to the involvement of multiple proteins. This study investigated the molecular targets of kaempferol. Ligand binding of kaempferol to liver X receptors (LXRs) was quantified by time-resolved fluorescence resonance energy transfer and surface plasmon resonance analyses. Kaempferol directly binds to and induces the transactivation of LXRs, with stronger specificity for the β-subtype (EC<inf>50</inf>=0.33μM). The oral administration of kaempferol in apolipoprotein-E-deficient mice (150mg/day/kg body weight) significantly reduced plasma glucose and increased high-density lipoprotein cholesterol levels and insulin sensitivity compared with the vehicle-fed control. Kaempferol also reduced plasma triglyceride concentrations and did not cause liver steatosis, a common side effect of potent LXR activation. In immunoblotting analysis, kaempferol reduced the nuclear accumulation of sterol regulatory element-binding protein-1 (SREBP-1). Our results show that the suppression of SREBP-1 activity and the selectivity for LXR-β over LXR-α by kaempferol contribute to the reductions of plasma and hepatic triglyceride concentrations in mice fed kaempferol. They also suggest that kaempferol activates LXR-β and suppresses SREBP-1 to enhance symptoms in metabolic syndrome.

Original languageEnglish
JournalJournal of Nutritional Biochemistry
DOIs
Publication statusAccepted/In press - 2014 Feb 22

Fingerprint

Liver
Sterol Regulatory Element Binding Protein 1
Plasmas
Triglycerides
kaempferol
Liver X Receptors
Glucose
Fluorescence Resonance Energy Transfer
Surface Plasmon Resonance
Surface plasmon resonance
Apolipoproteins E
Fatty Liver
Lipid Metabolism
Immunoblotting
Metabolism
HDL Cholesterol
Transcriptional Activation
Oral Administration
Insulin Resistance
Proteins

Keywords

  • Kaempferol
  • Liver X receptor
  • Metabolic syndrome
  • Peroxisome proliferation-activated receptor
  • Sterol regulatory element-binding protein-1c, Lipid metabolism

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Molecular Biology
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

Kaempferol ameliorates symptoms of metabolic syndrome by regulating activities of liver X receptor-β. / Hoang, Minh Hien; Jia, Yaoyao; Mok, Boram; Jun, Hee jin; Hwang, Kwang Yeon; Lee, Sung-Joon.

In: Journal of Nutritional Biochemistry, 22.02.2014.

Research output: Contribution to journalArticle

@article{b5d6c0b959fb4affa4ce7de68a962005,
title = "Kaempferol ameliorates symptoms of metabolic syndrome by regulating activities of liver X receptor-β",
abstract = "Kaempferol is a dietary flavonol previously shown to regulate cellular lipid and glucose metabolism. However, its molecular mechanisms of action and target proteins have remained elusive, probably due to the involvement of multiple proteins. This study investigated the molecular targets of kaempferol. Ligand binding of kaempferol to liver X receptors (LXRs) was quantified by time-resolved fluorescence resonance energy transfer and surface plasmon resonance analyses. Kaempferol directly binds to and induces the transactivation of LXRs, with stronger specificity for the β-subtype (EC50=0.33μM). The oral administration of kaempferol in apolipoprotein-E-deficient mice (150mg/day/kg body weight) significantly reduced plasma glucose and increased high-density lipoprotein cholesterol levels and insulin sensitivity compared with the vehicle-fed control. Kaempferol also reduced plasma triglyceride concentrations and did not cause liver steatosis, a common side effect of potent LXR activation. In immunoblotting analysis, kaempferol reduced the nuclear accumulation of sterol regulatory element-binding protein-1 (SREBP-1). Our results show that the suppression of SREBP-1 activity and the selectivity for LXR-β over LXR-α by kaempferol contribute to the reductions of plasma and hepatic triglyceride concentrations in mice fed kaempferol. They also suggest that kaempferol activates LXR-β and suppresses SREBP-1 to enhance symptoms in metabolic syndrome.",
keywords = "Kaempferol, Liver X receptor, Metabolic syndrome, Peroxisome proliferation-activated receptor, Sterol regulatory element-binding protein-1c, Lipid metabolism",
author = "Hoang, {Minh Hien} and Yaoyao Jia and Boram Mok and Jun, {Hee jin} and Hwang, {Kwang Yeon} and Sung-Joon Lee",
year = "2014",
month = "2",
day = "22",
doi = "10.1016/j.jnutbio.2015.03.005",
language = "English",
journal = "Journal of Nutritional Biochemistry",
issn = "0955-2863",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Kaempferol ameliorates symptoms of metabolic syndrome by regulating activities of liver X receptor-β

AU - Hoang, Minh Hien

AU - Jia, Yaoyao

AU - Mok, Boram

AU - Jun, Hee jin

AU - Hwang, Kwang Yeon

AU - Lee, Sung-Joon

PY - 2014/2/22

Y1 - 2014/2/22

N2 - Kaempferol is a dietary flavonol previously shown to regulate cellular lipid and glucose metabolism. However, its molecular mechanisms of action and target proteins have remained elusive, probably due to the involvement of multiple proteins. This study investigated the molecular targets of kaempferol. Ligand binding of kaempferol to liver X receptors (LXRs) was quantified by time-resolved fluorescence resonance energy transfer and surface plasmon resonance analyses. Kaempferol directly binds to and induces the transactivation of LXRs, with stronger specificity for the β-subtype (EC50=0.33μM). The oral administration of kaempferol in apolipoprotein-E-deficient mice (150mg/day/kg body weight) significantly reduced plasma glucose and increased high-density lipoprotein cholesterol levels and insulin sensitivity compared with the vehicle-fed control. Kaempferol also reduced plasma triglyceride concentrations and did not cause liver steatosis, a common side effect of potent LXR activation. In immunoblotting analysis, kaempferol reduced the nuclear accumulation of sterol regulatory element-binding protein-1 (SREBP-1). Our results show that the suppression of SREBP-1 activity and the selectivity for LXR-β over LXR-α by kaempferol contribute to the reductions of plasma and hepatic triglyceride concentrations in mice fed kaempferol. They also suggest that kaempferol activates LXR-β and suppresses SREBP-1 to enhance symptoms in metabolic syndrome.

AB - Kaempferol is a dietary flavonol previously shown to regulate cellular lipid and glucose metabolism. However, its molecular mechanisms of action and target proteins have remained elusive, probably due to the involvement of multiple proteins. This study investigated the molecular targets of kaempferol. Ligand binding of kaempferol to liver X receptors (LXRs) was quantified by time-resolved fluorescence resonance energy transfer and surface plasmon resonance analyses. Kaempferol directly binds to and induces the transactivation of LXRs, with stronger specificity for the β-subtype (EC50=0.33μM). The oral administration of kaempferol in apolipoprotein-E-deficient mice (150mg/day/kg body weight) significantly reduced plasma glucose and increased high-density lipoprotein cholesterol levels and insulin sensitivity compared with the vehicle-fed control. Kaempferol also reduced plasma triglyceride concentrations and did not cause liver steatosis, a common side effect of potent LXR activation. In immunoblotting analysis, kaempferol reduced the nuclear accumulation of sterol regulatory element-binding protein-1 (SREBP-1). Our results show that the suppression of SREBP-1 activity and the selectivity for LXR-β over LXR-α by kaempferol contribute to the reductions of plasma and hepatic triglyceride concentrations in mice fed kaempferol. They also suggest that kaempferol activates LXR-β and suppresses SREBP-1 to enhance symptoms in metabolic syndrome.

KW - Kaempferol

KW - Liver X receptor

KW - Metabolic syndrome

KW - Peroxisome proliferation-activated receptor

KW - Sterol regulatory element-binding protein-1c, Lipid metabolism

UR - http://www.scopus.com/inward/record.url?scp=84928963262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928963262&partnerID=8YFLogxK

U2 - 10.1016/j.jnutbio.2015.03.005

DO - 10.1016/j.jnutbio.2015.03.005

M3 - Article

C2 - 25959373

AN - SCOPUS:84931565968

JO - Journal of Nutritional Biochemistry

JF - Journal of Nutritional Biochemistry

SN - 0955-2863

ER -